Liu Yang, Deng Qiong, Yu Yang, Cao Xianwei, Xu Qunfei, Wan Lagen
Department of Clinical Laboratory, the First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Zhonghua Shao Shang Za Zhi. 2014 Feb;30(1):15-20.
To study the resistance mechanism and homology of carbapenems-resistant Pseudomonas aeruginosa (PA).
A total of 812 strains of PA (identified) were isolated from sputum, urine, blood, pus, and drainage of patients with burn, severe pneumonia, diabetes, chronic obstructive pneumonia, myocarditis, liver transplantation, or brainstem hemorrhage hospitalized from January to September 2012. Drug resistance of the 812 strains of PA to 15 antibiotics commonly used in clinic, including piperacillin, imipenem, etc., was tested using the automatic microorganism identifying and drug sensitivity analyzer. Among the carbapenems-resistant PA isolates, synergism test with imipenem-ethylene diamine tetraacetic acid (EDTA) and enhancement test with imipenem-EDTA and ceftazidime-EDTA were used to screen metallo-β-lactamase (MBL)-producing strains; modified Hodge test was used to screen strains producing Klebsiella pneumoniae carbapenemases (KPC); the carbapenemase gene, plasmid mediated quinolone resistant (PMQR) gene, and mobile genetic elements (MGE) were detected by polymerase chain reaction (PCR). In addition, a comparative analysis of the PMQR gene carrying level between the carbapenemase gene positive strains and carbapenemase gene negative strains was carried out. The repetitive consensus sequence of Enterobacteriaceae genome PCR (ERIC-PCR) was carried out for gene typing. Moreover, the source and resistance genes of strains with the same genotype were analyzed. Data were processed with Fisher's exact probability test.
The sensitive rates of the 812 strains of PA to ceftriaxone and trimethoprim-sulfamethoxazole were high, respectively 83.07% and 88.19%, and those of the other antibiotics ranged from 17.30% to 55.18%. Twenty-four carbapenems-resistant PA strains were screened, including 11 MBL-producing strains and 2 KPC-producing strains. Eleven carbapenems-resistant PA strains were found to harbor the blaVIM-2 gene, accounting for 45.83%; 2 carbapenems-resistant PA strains carried the blaKPC-2 gene, accounting for 8.33%. Fourteen carbapenems-resistant PA strains only harbored the PMQR gene acc (6')-Ib-cr, accounting for 58.33%; 3 carbapenems-resistant PA strains (12.50%) harbored the PMQR genes acc (6')-Ib-cr and qnr, including 1 strain with qnr A1 and 2 strains with qnr B4. Ten carbapenems-resistant PA strains carried the MGE gene ISCR1, accounting for 41.67%; 6 carbapenems-resistant PA strains carried the MGE gene ISEcp1, accounting for 25.00%. In addition, 3 carbapenems-resistant PA strains co-harbored the MGE genes ISCR1 and ISEcp1 (accounting for 12.50%), while only 1 carbapenems-resistant PA strain co-harbored the MGE genes class 1 integron and ISEcp1, accounting for 4.17%. Twelve out of the 13 carbapenemase gene positive strains carried one or two PMQR gene (s), which was significantly higher than that of the carbapenemase gene negative strains (with only five strains harboring one PMQR gene, P = 0.023). The 24 carbapenems-resistant PA strains were classified into 6 genotypes by the ERIC-PCR. Thirteen strains (accounting for 54.17%), mainly isolated from pus and blood samples, which were collected from burn department, were in genotype A. Eight out of the 13 strains harbored genes blaVIM-2, acc (6')-Ib-cr, and ISCR1. Five strains (accounting for 20.83%), mainly isolated from sputum samples which were collected from ICU, were in genotype B. Only 2 out of the 5 strains co-harbored the carbapenemase gene, PMQR gene, and MGE gene. There were respectively 2 strains in genotypes C and D, both accounting for 8.33%; the strains in different pattern were isolated from different wards, and they harbored diverse resistance genes. There were respectively 1 strain in genotypes E and F, both accounting for 4.17%.
The resistance mechanism of PA to carbapenems is mainly mediated by the VIM-2 type MBL in our hospital during 2012, followed by KPC-2 type carbapenemase, and the prevalent genotype is type A. The carbapenemase genes and PMQR genes co-carrying phenomenon exists among these strains of PA, which disseminated by clones.
研究耐碳青霉烯类铜绿假单胞菌(PA)的耐药机制及同源性。
收集2012年1月至9月住院的烧伤、重症肺炎、糖尿病、慢性阻塞性肺炎、心肌炎、肝移植或脑干出血患者的痰液、尿液、血液、脓液及引流液,共分离出812株PA(已鉴定)。采用全自动微生物鉴定及药敏分析仪检测812株PA对临床常用的15种抗生素(包括哌拉西林、亚胺培南等)的耐药情况。对耐碳青霉烯类PA分离株,采用亚胺培南 - 乙二胺四乙酸(EDTA)协同试验及亚胺培南 - EDTA和头孢他啶 - EDTA增强试验筛选产金属β - 内酰胺酶(MBL)菌株;改良Hodge试验筛选产肺炎克雷伯菌碳青霉烯酶(KPC)菌株;采用聚合酶链反应(PCR)检测碳青霉烯酶基因、质粒介导的喹诺酮耐药(PMQR)基因及可移动遗传元件(MGE)。此外,对碳青霉烯酶基因阳性菌株和碳青霉烯酶基因阴性菌株的PMQR基因携带水平进行比较分析。采用肠杆菌科基因组PCR重复共识序列(ERIC - PCR)进行基因分型。并分析相同基因型菌株的来源及耐药基因。数据采用Fisher确切概率法处理。
812株PA对头孢曲松和复方磺胺甲恶唑的敏感率较高,分别为83.07%和88.19%,对其他抗生素的敏感率在17.30%至55.18%之间。筛选出24株耐碳青霉烯类PA菌株,其中产MBL菌株11株,产KPC菌株2株。11株耐碳青霉烯类PA菌株携带blaVIM - 2基因,占45.83%;2株耐碳青霉烯类PA菌株携带blaKPC - 2基因,占8.33%。14株耐碳青霉烯类PA菌株仅携带PMQR基因acc(6') - Ib - cr,占58.33%;3株耐碳青霉烯类PA菌株(12.50%)携带PMQR基因acc(6') - Ib - cr和qnr,其中1株携带qnr A1,2株携带qnr B。10株耐碳青霉烯类PA菌株携带MGE基因ISCR1,占41.67%;6株耐碳青霉烯类PA菌株携带MGE基因ISEcp1,占25.00%。此外,3株耐碳青霉烯类PA菌株同时携带MGE基因ISCR1和ISEcp1(占12.50%),而仅1株耐碳青霉烯类PA菌株同时携带1类整合子和ISEcp1基因,占4.17%。13株碳青霉烯酶基因阳性菌株中有12株携带1个或2个PMQR基因,显著高于碳青霉烯酶基因阴性菌株(仅5株携带1个PMQR基因,P = 0.023)。24株耐碳青霉烯类PA菌株经ERIC - PCR分为6个基因型。13株(占54.17%)主要分离自烧伤科的脓液和血液样本,为A基因型。13株中有8株携带blaVIM - 2、acc(6') - Ib - cr和ISCR1基因。5株(占20.83%)主要分离自重症监护病房(ICU)的痰液样本,为B基因型。5株中仅2株同时携带碳青霉烯酶基因、PMQR基因和MGE基因。C和D基因型各有2株,均占8.33%;不同模式的菌株分离自不同病房,且携带不同耐药基因。E和F基因型各有1株,均占4.17%。
2012年我院PA对碳青霉烯类的耐药机制主要由VIM - 2型MBL介导,其次为KPC - 2型碳青霉烯酶,流行基因型为A基因型。这些PA菌株中存在碳青霉烯酶基因与PMQR基因共携带现象,且通过克隆传播。